p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells

Tong,Dongdong; Sun,Jing; Huang,Ping; Li,Minqi; Zhang,Fenghe

doi:10.3892/mmr.2017.6291

p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells

Authors:
- Dongdong Tong
- Jing Sun
- Ping Huang
- Minqi Li
- Fenghe Zhang
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, School of Stomatology, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Bone Metabolism, School of Stomatology, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Gynecology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: March 7, 2017 https://doi.org/10.3892/mmr.2017.6291
Pages: 2521-2529
Copyright: © Tong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study detected p75 neurotrophin receptor (p75NTR) expression in tongue squamous cell carcinoma (TSCC) cell lines, in order to define the biological properties of p75NTR+ cells and to confirm the use of p75NTR+ as a surface marker for TSCC stem cells. p75NTR+ cells were separated from Tca‑8113 and CAL‑27 TSCC cells by fluorescence‑activated cell sorting. Colony formation, MTT and scratch assays, and a tumorigenicity analysis were performed to measure self-renewal and proliferation, multidirectional differentiation, and tumorigenicity of p75NTR+ cells. p75NTR+ cells comprised 3.1 and 1.9% of Tca‑8113 and CAL‑27 cells (mean of three experiments), respectively, and were more able to form colonies compared with non‑sorted cells (P<0.01). In addition, the proportion of p75NTR+ cells generated from monoclonal p75NTR+ cells decreased to 14.5 (Tca‑8113) and 5.8% (CAL‑27) of cells within 2 weeks, thus suggesting that p75NTR+ cells are able to generate p75NTR+ and p75NTR‑ cells. Furthermore, p75NTR+ cells exhibited increased proliferation, as evidenced by MTT assay (P<0.01) and had greater metastatic ability according to the scratch assay (P<0.01), compared with non‑sorted cells. p75NTR+ cells also exhibited a greater tumorigenic capacity compared with non‑sorted cells. In conclusion, p75NTR+ cells isolated from TSCC cell lines possess the characteristics of cancer stem cells; therefore, p75NTR may be considered a useful surface marker for the identification of TSCC stem cells.

View Figures

View References

1	Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009. View Article : Google Scholar : PubMed/NCBI
2	Hamburger AW and Salmon SE: Primary bioassay of human tumor stem cells. Science. 197:461–463. 1977. View Article : Google Scholar : PubMed/NCBI
3	Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
4	Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature. 432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
5	Costea DE, Tsinkalovsky O, Vintermyr OK, Johannessen AC and Mackenzie IC: Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis. 12:443–454. 2006. View Article : Google Scholar : PubMed/NCBI
6	Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:5821–5828. 2003.PubMed/NCBI
7	Seigel GM, Campbell LM, Narayan M and Gonzalez-Fernandez F: Cancer stem cell characteristics in retinoblastoma. Mol Vis. 11:729–737. 2005.PubMed/NCBI
8	Chumsri S, Phatak P, Edelman MJ, Khakpour N, Hamburger AW and Burger AM: Cancer stem cells and individualized therapy. Cancer Genomics Proteomics. 4:165–74. 2007.PubMed/NCBI
9	Locke M, Heywood M, Fawell S and Mackenzie IC: Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 65:8944–8950. 2005. View Article : Google Scholar : PubMed/NCBI
10	Tudor D, Locke M, Owen-Jones E and Mackenzie IC: Intrinsic patterns of behavior of epithelial stem cells. J Investig Dermatol Symp Proc. 9:208–214. 2004. View Article : Google Scholar : PubMed/NCBI
11	Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005. View Article : Google Scholar : PubMed/NCBI
12	Kiyosue T, Kawano S, Matsubara R, Goto Y, Hirano M, Jinno T, Toyoshima T, Kitamura R, Oobu K and Nakamura S: Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Int J Clin Oncol. 18:154–163. 2013. View Article : Google Scholar : PubMed/NCBI
13	Rabizadeh S and Bredesen DE: Ten years on: Mediation of cell death by the common neurotrophin receptor p75(NTR). Cytokine Growth Factor Rev. 14:225–239. 2003. View Article : Google Scholar : PubMed/NCBI
14	Liepinsh E, Ilag LL, Otting G and Ibáñez CF: NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 16:4999–5005. 1997. View Article : Google Scholar : PubMed/NCBI
15	Rodríguez-Tébar A, Dechant G, Götz R and Barde YA: Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J. 11:917–922. 1992.PubMed/NCBI
16	Wang X, Bauer JH, Li Y, Shao ZH, Zetoune FS, Cattaneo E and Vincenz C: Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model. J Biol Chem. 276:33812–33820. 2001. View Article : Google Scholar : PubMed/NCBI
17	Harding TC, Xue L, Bienemann A, Haywood D, Dickens M, Tolkovsky AM and Uney JB: Inhibition of JNK by overexpression of the JNL binding domain of JIP-1 prevents apoptosis in sympathetic neurons. J Biol Chem. 276:4531–4534. 2001. View Article : Google Scholar : PubMed/NCBI
18	Park DS, Morris EJ, Bremner R, Keramaris E, Padmanabhan J, Rosenbaum M, Shelanski ML, Geller HM and Greene LA: Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci. 20:3104–3114. 2000.PubMed/NCBI
19	Salehi AH, Xanthoudakis S and Barker PA: NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem. 277:48043–48050. 2002. View Article : Google Scholar : PubMed/NCBI
20	Krygier S and Djakiew D: Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. Int J Cancer. 98:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
21	Khwaja F and Djakiew D: Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor. Mol Carcinog. 36:153–160. 2003. View Article : Google Scholar : PubMed/NCBI
22	Pflug BR, Onoda M, Lynch JH and Djakiew D: Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res. 52:5403–5406. 1992.PubMed/NCBI
23	Okumura T, Shimada Y, Imamura M and Yasumoto S: Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene. 22:4017–4026. 2003. View Article : Google Scholar : PubMed/NCBI
24	Campagnolo L, Russo MA, Puglianiello A, Favale A and Siracusa G: Mesenchymal cell precursors of peritubular smooth muscle cells of the mouse testis can be identified by the presence of the p75 neurotrophin receptor. Biol Reprod. 64:464–472. 2001. View Article : Google Scholar : PubMed/NCBI
25	Yamamoto N, Akamatsu H, Hasegawa S, Yamada T, Nakata S, Ohkuma M, Miyachi E, Marunouchi T and Matsunaga K: Isolation of multipotent stem cells from mouse adipose tissue. J Dermatol Sci. 48:43–52. 2007. View Article : Google Scholar : PubMed/NCBI
26	Qi H, Li DQ, Shine HD, Chen Z, Yoon KC, Jones DB and Pflugfelder SC: Nerve growth factor and its receptor TrkA serve as potential markers for human corneal epithelial progenitor cells. Exp Eye Res. 86:34–40. 2008. View Article : Google Scholar : PubMed/NCBI
27	Rota LM, Lazzarino DA, Ziegler AN, LeRoith D and Wood TL: Determining mammosphere-forming potential: Application of the limiting dilution analysis. J Mammary Gland Biol Neoplasia. 17:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
28	Liang CC, Park AY and Guan JL: In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
29	Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
30	Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
31	Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ and Guan XY: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
32	Zen Y, Fujii T, Yoshikawa S, Takamura H, Tani T, Ohta T and Nakanuma Y: Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol. 170:1750–1762. 2007. View Article : Google Scholar : PubMed/NCBI
33	Seo DC, Sung JM, Cho HJ, Yi H, Seo KH, Choi IS, Kim DK, Kim JS, El-Aty AMA and Shin HC: Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer. 6:752007. View Article : Google Scholar : PubMed/NCBI
34	Liu SL, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
35	Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature. 445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
36	Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
37	Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V and Yamashita S: Characterization of side population in thyroid cancer cell lines: Cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 148:1797–1803. 2007. View Article : Google Scholar : PubMed/NCBI
38	Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
39	Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
40	Jin H, Pan Y, Zhao L, Zhai H, Li X, Sun L, He L, Chen Y, Hong L, Du Y and Fan D: p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia. 9:471–478. 2007. View Article : Google Scholar : PubMed/NCBI
41	Dimaras H and Gallie BL: The p75 (NTR) neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development. Int J Cancer. 122:2023–2029. 2008. View Article : Google Scholar : PubMed/NCBI
42	Khwaja F, Tabassum A, Allen J and Djakiew D: The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun. 341:1184–1192. 2006. View Article : Google Scholar : PubMed/NCBI
43	Dang CX, Zhang Y, Ma QY and Shimahara Y: Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. J Gastroen Hepatol. 21:850–858. 2006. View Article : Google Scholar
44	Marchetti D, Aucoin R, Blust J, Murry B and Greiter-Wilke A: p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J Cell Biochem. 91:206–215. 2004. View Article : Google Scholar : PubMed/NCBI
45	Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M and Dirks PB: Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 3:268–273. 2007. View Article : Google Scholar : PubMed/NCBI
46	Soland TM, Brusevold IJ, Koppang HS, Schenck K and Bryne M: Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma. Histopathology. 53:62–72. 2008. View Article : Google Scholar : PubMed/NCBI